Topical nepafenac formulations

Details Topical nepafenac formulations Topical nepafenac formulations

2005-12-02

2010-11-16

Vu, Jake M. (Department: 1618)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

C424S486000

Reexamination Certificate

active

07834059

ABSTRACT:
Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.

REFERENCES:
patent: 3828093 (1974-08-01), Bays et al.
patent: 4045576 (1977-08-01), Welstead, Jr. et al.
patent: 4126635 (1978-11-01), Welstead, Jr. et al.
patent: 4182774 (1980-01-01), Welstead, Jr. et al.
patent: 4254146 (1981-03-01), Walsh
patent: 4313949 (1982-02-01), Shanklin, Jr. et al.
patent: 4503073 (1985-03-01), Walsh et al.
patent: 4568695 (1986-02-01), Moran et al.
patent: 4683242 (1987-07-01), Poser
patent: 4783487 (1988-11-01), Brune
patent: 4851443 (1989-07-01), Brune
patent: 4910225 (1990-03-01), Ogawa et al.
patent: 5073641 (1991-12-01), Bundgaard et al.
patent: 5461081 (1995-10-01), Ali et al.
patent: 5475034 (1995-12-01), Yanni et al.
patent: 5521222 (1996-05-01), Ali et al.
patent: 5624893 (1997-04-01), Yanni
patent: 6342524 (2002-01-01), Hellberg et al.
patent: 6638976 (2003-10-01), Gamache et al.
patent: 2002/0037929 (2002-03-01), Kapin et al.
patent: 2003/0207941 (2003-11-01), Bingaman et al.
patent: 2005/0239895 (2005-10-01), Sawa et al.
patent: 2 071 086 (1981-09-01), None
patent: 2 093 027 (1982-08-01), None
patent: WO 02/13805 (2002-02-01), None
patent: WO 03/092669 (2003-11-01), None
Penn et al. Studies of the Effect and Mechanism of Action of Topical Nepafenac in Rat Model of ROP. ARVO Annual Meeting, Abstract No. 2741, (2002).
Sancilio et al., “AHR-10037, a non-steroidal anti-inflammatory compound of low gastric toxicity,”Agents and Actions, vol. 31, pp. 117-126 (1990).
Ke et al., “Nepafenac, A Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation,”Inflammation, vol. 24(4), pp. 371-384 (2000).
Walsh et al., “Antiinflammatory Agents. 3. Synthesis and Pharmacological Evaluation of 2-Amino-3-benzoyl phenylacetic Acid and Analogues,”J. Med. Chem. vol. 27(11), pp. 1379-1388 (1984).
Walsh et al., “Antiinflammatory Agents. 4. Syntheses and Biological Evaluation of Potential Prodrugs of 2-Amino-3-benzoylbenzeneacetic Acid and 2-Amino-3-(4-chlorobenzoyl)benzeneacetic Acid,”J. Med. Chem., vol. 33, pp. 2296-2304 (1990).
Penn et al., “Studies of the Effect and Mechanism of Action of Topical Nepafenac in a Rat Model of ROP,”ARVO Annual Meeting, Abstract No. 2741, 2002.

Affiliated with

Also associated with

Rating

Topical nepafenac formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical nepafenac formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical nepafenac formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4164964